Zevra Therapeutics, Inc. (ZVRA) Impairment of intangible assets — Quarterly & Annual

Screener

Impairment of intangible assets at other companies

The RMR GroupRMR

$19.07M—

StoneX Group Inc.SNEX

$0—

Citizens Financial Services, Inc.CZFS

$0—

Zevra Therapeutics, Inc.ZVRA

$0-100%

KemperKMPR

$5.43M—

Mayville EngineeringMEC

$0—

Other financials

Income statement

Revenue$39.7M+53.3%

Gross profit$38.1M+182%

Operating income$16.8M+124%

Net income$8.8M-88.3%

EPS (diluted)$0.14-88.4%

Balance sheet

Cash & equivalents$145.3M+205%

Total debt$1.5M-97.6%

Total equity$217.7M+85.7%

Total assets$302.7M+18.1%

Cash flow

Operating cash flow$17.0M+573%

CapEx$217.0K+1.9%

Free cash flow$16.8M+541%

Valuation

Market cap$622.48M-0.8%

Enterprise value$478.66M-25.5%

P/E10.7×-227×

P/S4.6×-5.5×

Profitability

Gross margin95.5%+23.5pp

Operating margin-103.9%-43.0pp

Net margin42.8%+38.6pp

FCF margin-75%-30.5pp

Returns & leverage

Return on equity34.8%+31.3pp

Debt / equity0×-0.5×

Current ratio5.2×-2.7×

Where this comes from

Reported directly by Zevra Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill.

The source filing: Zevra Therapeutics, Inc.’s 10-Q, filed August 5, 2026. Open the filing →

Filed: Aug 5, 2026, 5:19 PM EDT
Fiscal quarter: Q2 FY2026
Calendar quarter: Q2 2026
Accession: 0001434647-26-000068

FAQ

What is Zevra Therapeutics, Inc.'s impairment of intangible assets?: Zevra Therapeutics, Inc. (ZVRA) reported impairment of intangible assets of $0 in Q2 2026.
What does impairment of intangible assets mean?: Impairment of intangible assets as reported by Zevra Therapeutics, Inc. Common Stock.

Ask your AI about Zevra Therapeutics, Inc.'s impairment of intangible assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk